Role of endocannabinoids on sweet taste perception, food preference, and obesity-related disorders

Chemical Senses

Volumn 43, Issue 1, 2018, Pages 3-16

  Tarragon, Ernesto ^a   Moreno, Juan José ^b,c  

^a UNIVERSITY OF TRIER   (Germany)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

2 arachidonoylglycerol; Anandamide; Inflammation; Natural reinforcers reward; Sweet taste; Type 2 diabetes

Indexed keywords

CANNABINOID RECEPTOR; ENDOCANNABINOID; RECEPTOR PROTEIN; T1R2 RECEPTOR; T1R3 RECEPTOR; UNCLASSIFIED DRUG; G PROTEIN COUPLED RECEPTOR; TASTE RECEPTORS, TYPE 1;

ENERGY METABOLISM; EXPERIENCE; FEEDING BEHAVIOR; FLAVOR; FOOD INTAKE; FOOD PREFERENCE; GENETIC CODE; GENETIC VARIATION; HUMAN; INSULIN RESISTANCE; LIFESTYLE; METABOLIC SYNDROME X; NEUROMODULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; STRESS; SWEETNESS; TASTE DISCRIMINATION; COMPLICATION; GENETIC POLYMORPHISM; GENETICS; INFLAMMATION; MENTAL STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SUGAR INTAKE; TASTE;

DIABETES MELLITUS, TYPE 2; DIETARY SUGARS; ENDOCANNABINOIDS; FEEDING BEHAVIOR; FOOD PREFERENCES; HUMANS; INFLAMMATION; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, CANNABINOID; RECEPTORS, G-PROTEIN-COUPLED; STRESS, PSYCHOLOGICAL; TASTE PERCEPTION;

EID: 85040632252     PISSN: 0379864X     EISSN: 14643553     Source Type: Journal    
DOI: 10.1093/chemse/bjx062     Document Type: Review

References (132)

1. Agrawal A, Nelson EC, Littlefield AK, Bucholz KK, Degenhardt L, Henders AK, Madden PA, Martin NG, Montgomery GW, Pergadia ML, et al. 2012. Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression. Arch Gen Psychiatry. 69:732-740.
2. Akirav I. 2013. Cannabinoids and glucocorticoids modulate emotional memory after stress. Neurosci Biobehav Rev. 37:2554-2563.
3. Alger BE, Kim J. 2011. Supply and demand for endocannabinoids. Trends Neurosci. 34:304-315.
4. Argueta DA, DiPatrizio NV. 2017. Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity. Physiol Behav. 171:32-39.
5. Ballon N, Leroy S, Roy C, Bourdel MC, Charles-Nicolas A, Krebs MO, Poirier MF. 2006. (AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population. Pharmacogenomics J. 6:126-130.
6. Bátkai S, Osei-Hyiaman D, Pan H, El-Assal O, Rajesh M, Mukhopadhyay P, Hong F, Harvey-White J, Jafri A, Haskó G, et al. 2007. Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury. FASEB J. 21:1788-1800.
7. Behrens M, Meyerhof W. 2011. Gustatory and extragustatory functions of mammalian taste receptors. Physiol Behav. 105:4-13.
8. Berge K, Piscitelli F, Hoem N, Silvestri C, Meyer I, Banni S, Di Marzo V. 2013. Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men. Lipids Health Dis. 12:78.
9. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V. 2001. Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proc Natl Acad Sci U S A. 98:6402-6406.
10. Bermudez-Silva FJ, Viveros MP, McPartland JM, Rodriguez de Fonseca F. 2010. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Pharmacol Biochem Behav. 95:375-382.
11. Berridge KC, Ho CY, Richard JM, DiFeliceantonio AG. 2010. The tempted brain eats: pleasure and desire circuits in obesity and eating disorders. Brain Res. 1350:43-64.
12. Berthoud HR. 2011. Metabolic and hedonic drives in the neural control of appetite: who is the boss? Curr Opin Neurobiol. 21:888-896.
13. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, et al. 2003. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol. 163:463-468.
14. Bisogno T, Ligresti A, Di Marzo V. 2005. The endocannabinoid signalling system: biochemical aspects. Pharmacol Biochem Behav. 81:224-238.
15. Bowen DJ, Barrington WE, Beresford SAA, De Jong JW, Vanderschuren LJMJ, Adan R, Murray S, Tulloch A, Gold MS, Avena NM. 2014. Hormonal and neural mechanisms of food reward, eating behaviour and obesity. Obes Facts. 5:1-51.
16. Bradshaw HB, Rimmerman N, Hu SS, Benton VM, Stuart JM, Masuda K, Cravatt BF, O'Dell DK, Walker JM. 2009. The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. BMC Biochem. 10:14.
17. Bray GA, Popkin BM. 2014. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar. Diabetes Care. 37:950-956.
18. Breslin PA, Spector AC. 2008. Mammalian taste perception. Curr Biol. 18:R148-R155.
19. Cao Z, Mulvihill MM, Mukhopadhyay P, Xu H, Erdélyi K, Hao E, Holovac E, Haskó G, Cravatt BF, Nomura DK, et al. 2013. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice. Gastroenterology. 144:808-817.e15.
20. Carracedo A, Geelen MJ, Diez M, Hanada K, Guzmán M, Velasco G. 2004. Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids. Biochem J. 380:435-440.
21. Cartoni C, Yasumatsu K, Ohkuri T, Shigemura N, Yoshida R, Godinot N, le Coutre J, Ninomiya Y, Damak S. 2010. Taste preference for fatty acids is mediated by GPR40 and GPR120. J Neurosci. 30:8376-8382.
22. Chen DJ, Gao M, Gao FF, Su QX, Wu J. 2017. Brain cannabinoid receptor 2: expression, function and modulation. Acta Pharmacol Sin. 38:312- 316.
23. Coskun ZM, Bolkent S. 2014. Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with ?9- THC. Cell Biochem Funct. 32:612-619.
24. Cota D, Tschöp MH, Horvath TL, Levine AS. 2006. Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res Rev. 51:85-107.
25. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. 1996. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 384:83-87.
26. Das A. 2016. Psychosocial distress and inflammation: which way does causality flow? Soc Sci Med. 170:1-8.
27. Deshmukh RR, Sharma PL. 2012. Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats. Pharmacol Res. 66:276-282.
28. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1946-1949.
29. Devaraj S, Wang-Polagruto J, Polagruto J, Keen CL, Jialal I. 2008. High-fat, energy-dense, fast-food-style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism. 57:867-870.
30. Dias AG, Eny KM, Cockburn M, Chiu W, Nielsen DE, Duizer L, El-Sohemy A. 2015. Variation in the TAS1R2 gene, sweet taste perception and intake of sugars. J Nutrigenet Nutrigenomics. 8:81-90.
31. Ding C, Chan Z, Magkos F. 2016. Lean, but not healthy: the 'metabolically obese, normal-weight' phenotype. Curr Opin Clin Nutr Metab Care. 19:408-417.
32. DiPatrizio NV. 2014. Is fat taste ready for primetime? Physiol Behav. 136:145-154.
33. DiPatrizio NV, Joslin A, Jung KM, Piomelli D. 2013. Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. FASEB J. 27:2513-2520.
34. DiPatrizio NV, Simansky KJ. 2008. Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats. J Neurosci. 28:9702-9709.
35. DiPatrizio NV, Astarita G, Schwartz G, Li X, Piomelli D. 2011. Endocannabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci USA. 108:12904-12908.
36. Dipatrizio NV, Simansky KJ. 2008. Inhibiting parabrachial fatty acid amide hydrolase activity selectively increases the intake of palatable food via cannabinoid CB1 receptors. Am J Physiol Regul Integr Comp Physiol. 295:R1409-R1414.
37. Dlugos A, Childs E, Stuhr KL, Hillard CJ, de Wit H. 2012. Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology. 37:2416-2427.
38. Dore R, Valenza M, Wang X, Rice KC, Sabino V, Cottone P. 2014. The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food. Addict Biol. 19:849-861.
39. Dotson CD, Colbert CL, Garcea M, Smith JC, Spector AC. 2012. The consequences of gustatory deafferentation on body mass and feeding patterns in the rat. Am J Physiol Regul Integr Comp Physiol. 303:R611-R623.
40. Eny KM, Wolever TM, Corey PN, El-Sohemy A. 2010. Genetic variation in TAS1R2 (Ile191Val) is associated with consumption of sugars in overweight and obese individuals in 2 distinct populations. Am J Clin Nutr. 92:1501-1510.
41. Escartín-Pérez RE, Cendejas-Trejo NM, Cruz-Martínez AM, González- Hernández B, Mancilla-Díaz JM, Florán-Garduño B. 2009. Role of cannabinoid CB1 receptors on macronutrient selection and satiety in rats. Physiol Behav. 96:646-650.
42. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. 2010. Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues. Neuropsychopharmacology. 35:967-975.
43. Frost M, Nielsen TL, Wraae K, Hagen C, Piters E, Beckers S, De Freitas F, Brixen K, Van Hul W, Andersen M. 2010. Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution. Eur J Endocrinol. 163:407-412.
44. Fushan AA, Simons CT, Slack JP, Drayna D. 2010. Association between common variation in genes encoding sweet taste signaling components and human sucrose perception. Chem Senses. 35:579-592.
45. Fushan AA, Simons CT, Slack JP, Manichaikul A, Drayna D. 2009. Allelic polymorphism within the TAS1R3 promoter is associated with human taste sensitivity to sucrose. Curr Biol. 19:1288-1293.
46. Gaillard D, Passilly-Degrace P, Besnard P. 2008. Molecular mechanisms of fat preference and overeating. Ann N Y Acad Sci. 1141:163-175.
47. Gazzerro P, Caruso MG, Notarnicola M, Misciagna G, Guerra V, Laezza C, Bifulco M. 2007. Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population. Int J Obes (Lond). 31:908-912.
48. Ge Q, Maury E, Rycken L, Gérard J, Noël L, Detry R, Navez B, Brichard SM. 2013. Endocannabinoids regulate adipokine production and the immune balance of omental adipose tissue in human obesity. Int J Obes (Lond). 37:874-880.
49. Gruden G, Barutta F, Kunos G, Pacher P. 2016. Role of the endocannabinoid system in diabetes and diabetic complications. Br J Pharmacol. 173:1116- 1127.
50. Halaris A. 2017. Inflammation-associated co-morbidity between depression and cardiovascular disease. Curr Top Behav Neurosci. 31:45-70.
51. Han KH, Lim S, Ryu J, Lee CW, Kim Y, Kang JH, Kang SS, Ahn YK, Park CS, Kim JJ. 2009. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc Res. 84:378-386.
52. Hardwick JP, Eckman K, Lee YK, Abdelmegeed MA, Esterle A, Chilian WM, Chiang JY, Song BJ. 2013. Eicosanoids in metabolic syndrome. Adv Pharmacol. 66:157-266.
53. Hariri AR, Gorka A, Hyde LW, Kimak M, Halder I, Ducci F, Ferrell RE, Goldman D, Manuck SB. 2009. Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain function. Biol Psychiatry. 66:9-16.
54. Haughey HM, Marshall E, Schacht JP, Louis A, Hutchison KE. 2008. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction. 103:1678-1686.
55. Haznedaroglu E, Koldemir-Gündüz M, Bakir-Coskun N, Bozkus HM, çagatay P, Süsleyici-Duman B, Mentes A. 2015. Association of sweet taste receptor gene polymorphisms with dental caries experience in school children. Caries Res. 49:275-281.
56. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. 1991. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci. 11:563- 583.
57. Higgs S, Williams CM, Kirkham TC. 2003. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716. Psychopharmacology (Berl). 165:370-377.
58. Higuchi S, Irie K, Mishima S, Araki M, Ohji M, Shirakawa A, Akitake Y, Matsuyama K, Mishima K, Mishima K, et al. 2010. The cannabinoid 1-receptor silent antagonist O-2050 attenuates preference for high-fat diet and activated astrocytes in mice. J Pharmacol Sci. 112:369-372.
59. Hill MN, Bierer LM, Makotkine I, Golier JA, Galea S, McEwen BS, Hillard CJ, Yehuda R. 2013. Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the World Trade Center attacks. Psychoneuroendocrinology. 38:2952-2961.
60. Hill MN, McEwen BS. 2010. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog Neuropsychopharmacol Biol Psychiatry. 34:791-797.
61. Hill MN, Tasker JG. 2012. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitaryadrenal axis. Neuroscience. 204:5-16.
62. Jager G, Witkamp RF. 2014. The endocannabinoid system and appetite: relevance for food reward. Nutr Res Rev. 27:172-185.
63. Jorgacevic B, Mladenovic D, Ninkovic M, Veskovic M, Dragutinovic V, Vatazevic A, Vucevic D, Ješic Vukicevic R, Radosavljevic T. 2015. Rimonabant improves oxidative/nitrosative stress in mice with nonalcoholic fatty liver disease. Oxid Med Cell Longev. 2015:842108.
64. Joseph PV, Reed DR, Mennella JA. 2016. Individual differences among children in sucrose detection thresholds: relationship with age, gender, and bitter taste genotype. Nurs Res. 65:3-12.
65. Jourdan T, Godlewski G, Kunos G. 2016. Endocannabinoid regulation of ß-cell functions: implications for glycaemic control and diabetes. Diabetes Obes Metab. 18:549-557.
66. Juhasz G, Chase D, Pegg E, Downey D, Toth ZG, Stones K, Platt H, Mekli K, Payton A, Elliott R, et al. 2009. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology. 34:2019-2027.
67. Jyotaki M, Shigemura N, Ninomiya Y. 2010. Modulation of sweet taste sensitivity by orexigenic and anorexigenic factors. Endocr J. 57:467- 475.
68. Kaye WH, Fudge JL, Paulus M. 2009. New insights into symptoms and neurocircuit function of anorexia nervosa. Nat Rev Neurosci. 10:573-584.
69. Keskitalo K, Knaapila A, Kallela M, Palotie A, Wessman M, Sammalisto S, Peltonen L, Tuorila H, Perola M. 2007. Sweet taste preferences are partly genetically determined: identification of a trait locus on chromosome 16. Am J Clin Nutr. 86:55-63. Available at http://www.ncbi.nlm.nih.gov/pubmed/ 17616763.
70. Kim UK, Wooding S, Riaz N, Jorde LB, Drayna D. 2006. Variation in the human TAS1R taste receptor genes. Chem Senses. 31:599-611.
71. Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H. 2003. The cannabinoid system and immune modulation. J Leukoc Biol. 74:486- 496.
72. Kochem M, Breslin PA. 2017. Lipid-lowering pharmaceutical clofibrate inhibits human sweet taste. Chem Senses. 42:79-83.
73. Kojima I, Nakagawa Y, Ohtsu Y, Hamano K, Medina J, Nagasawa M. 2015. Return of the glucoreceptor: glucose activates the glucose-sensing receptor T1R3 and facilitates metabolism in pancreatic ß-cells. J Diabetes Investig. 6:256-263.
74. Kral TV, Rauh EM. 2010. Eating behaviors of children in the context of their family environment. Physiol Behav. 100:567-573.
75. Kvaløy K, Holmen J, Hveem K, Holmen TL. 2015. Genetic effects on longitudinal changes from healthy to adverse weight and metabolic status - The HUNT study. PLoS One. 10:e0139632.
76. Laczmanski L, Milewicz A, Dunajska K, Jedrzejczuk D, Pawlak M, Lwow F. 2011. Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women. Gynecol Endocrinol. 27:1023-1027.
77. Laffitte A, Neiers F, Briand L. 2014. Functional roles of the sweet taste receptor in oral and extraoral tissues. Curr Opin Clin Nutr Metab Care. 17:379- 385.
78. Liem DG, Mennella JA. 2002. Sweet and sour preferences during childhood: role of early experiences. Dev Psychobiol. 41:388-395.
79. Nogueiras R, Veyrat-Durebex C, Suchanek PM, Klein M, Tschöp J, Caldwell C, Woods SC, Wittmann G, Watanabe M, Liposits Z, et al. 2008. Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes. 57:2977-2991.
80. Nong L, Newton C, Friedman H, Klein TW. 2001. CB1 and CB2 receptor mRNA expression in human peripheral blood mononuclear cells (PBMC) from various donor types. In: Neuroimmune circuits, drugs of abuse, and infectious diseases. US: Springer, p. 229-233.
81. O'Keefe L, Simcocks AC, Hryciw DH, Mathai ML, McAinch AJ. 2014. The cannabinoid receptor 1 and its role in influencing peripheral metabolism. Diabetes Obes Metab. 16:294-304.
82. Oberndorfer TA, Frank GK, Simmons AN, Wagner A, McCurdy D, Fudge JL, Yang TT, Paulus MP, Kaye WH. 2013. Altered insula response to sweet taste processing after recovery from anorexia and bulimia nervosa. Am J Psychiatry. 170:1143-1151.
83. Oddi S, Fezza F, Pasquariello N, De Simone C, Rapino C, Dainese E, Finazzi-Agrò A, Maccarrone M. 2008. Evidence for the intracellular accumulation of anandamide in adiposomes. Cell Mol Life Sci. 65:840-850.
84. Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. 2004. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem. 279:5298-5305.
85. Olson CM, Gemmill KP. 1981. Association of sweet preference and food selection among four to five year old children. Ecol Food Nutr. 11:145-150.
86. Pawellek I, Grote V, Rzehak P, Xhonneux A, Verduci E, Stolarczyk A, Closa- Monasterolo R, Reischl E, Koletzko B; European Childhood Obesity Trial Study Group. 2016. Association of TAS2R38 variants with sweet food intake in children aged 1-6 years. Appetite. 107:126-134.
87. Peeters A, Beckers S, Mertens I, Van Hul W, Van Gaal L. 2007. The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men. Endocrine. 31:138-141.
88. Pelchat ML, Johnson A, Chan R, Valdez J, Ragland JD. 2004. Images of desire: food-craving activation during fMRI. Neuroimage. 23:1486-1493.
89. Pepino MY, Mennella JA. 2005a. Sucrose-induced analgesia is related to sweet preferences in children but not adults. Pain. 119:210-218.
90. Pepino MY, Mennella JA. 2005b. Factors contributing to individual differences in sucrose preference. Chem Senses. 30 (Suppl 1):i319-i320.
91. Petersen G, Sørensen C, Schmid PC, Artmann A, Tang-Christensen M, Hansen SH, Larsen PJ, Schmid HH, Hansen HS. 2006. Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors. Biochim Biophys Acta. 1761:143-50.
92. Pi-Sunyer FX, Aronne LJ, Heshmati HM, Devin J, Rosenstock J; RIO-North America Study Group. 2006. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA. 295:761-775.
93. Poddar M, Chetty Y, Chetty VT. 2017. How does obesity affect the endocrine system? A narrative review. Clin Obes. 7:136-144.
94. Prasad K, Dhar I. 2014. Oxidative stress as a mechanism of added sugarinduced cardiovascular disease. Int J Angiol. 23:217-226.
95. Prindiville EA, Marshall RT, Heymann H. 1999. Effect of milk fat on the sensory properties of chocolate ice cream. J Dairy Sci. 82:1425-1432.
96. Prindiville EA, Marshall RT, Heymann H. 2000. Effect of milk fat, cocoa butter, and whey protein fat replacers on the sensory properties of lowfat and nonfat chocolate ice cream. J Dairy Sci. 83:2216-2223.
97. Rademacher DJ, Hillard CJ. 2007. Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. Prog Neuropsychopharmacol Biol Psychiatry. 31:633-641.
98. Ramírez-López MT, Vázquez M, Bindila L, Lomazzo E, Hofmann C, Blanco RN, Alén F, Antón M, Decara J, Ouro D, et al. 2015. Exposure to a highly caloric palatable diet during pregestational and gestational periods affects hypothalamic and hippocampal endocannabinoid levels at birth and induces adiposity and anxiety-like behaviors in male rat offspring. Front Behav Neurosci. 9:339.
99. Ramos-Lopez O, Panduro A, Martinez-Lopez E, Roman S. 2016. Sweet taste receptor TAS1R2 polymorphism (Val191Val) is associated with a higher carbohydrate intake and hypertriglyceridemia among the population of West Mexico. Nutrients. 8:101.
100. Reed DR, Margolskee RF. 2010. Gustation genetics: sweet gustducin! Chem Senses. 35:549-550.
101. Ribeiro R, Wen J, Li S, Zhang Y. 2013. Involvement of ERK1/2, cPLA2 and NF-κB in microglia suppression by cannabinoid receptor agonists and antagonists. Prostaglandins Other Lipid Mediat. 100-101:1-14.
102. Roche R, Hoareau L, Bes-Houtmann S, Gonthier MP, Laborde C, Baron JF, Haffaf Y, Cesari M, Festy F. 2006. Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes. Histochem Cell Biol. 126:177-187.
103. Rohrbach K, Thomas MA, Glick S, Fung EN, Wang V, Watson L, Gregory P, Antel J, Pelleymounter MA. 2012. Ibipinabant attenuates ß-cell loss in male Zucker diabetic fatty rats independently of its effects on body weight. Diabetes Obes Metab. 14:555-564.
104. Rolls ET. 2016. Functions of the anterior insula in taste, autonomic, and related functions. Brain Cogn. 110:4-19.
105. Romero-Zerbo SY, Bermúdez-Silva FJ. 2014. Cannabinoids, eating behaviour, and energy homeostasis. Drug Test Anal. 6:52-58.
106. Running CA, Craig BA, Mattes RD. 2015. Oleogustus: the unique taste of fat. Chem Senses. 40:507-516.
107. Sarinopoulos I, Dixon GE, Short SJ, Davidson RJ, Nitschke JB. 2006. Brain mechanisms of expectation associated with insula and amygdala response to aversive taste: implications for placebo. Brain Behav Immun. 20:120- 132.
108. Scheen AJ, Finer N, Hollander P, Jensen MD, Van Gaal LF; RIO-Diabetes Study Group. 2006. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet. 368:1660-1672.
109. Shrinivasan M, Skariyachan S, Aparna V, Kolte VR. 2012. Homology modelling of CB1 receptor and selection of potential inhibitor against obesity. Bioinformation. 8:523-528.
110. Siegel KR, McKeever Bullard K, Imperatore G, Kahn HS, Stein AD, Ali MK, Narayan KM. 2016. Association of higher consumption of foods derived from subsidized commodities with adverse cardiometabolic risk among US adults. JAMA Intern Med. 312:189-190.
111. Siegfried Z, Kanyas K, Latzer Y, Karni O, Bloch M, Lerer B, Berry EM. 2004. Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/ purging subtypes. Am J Med Genet B Neuropsychiatr Genet. 125B:126-130.
112. Simopoulos AP. 2016. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 8:1-17.
113. Smith KR, Hussain T, Karimian Azari E, Steiner JL, Ayala JE, Pratley RE, Kyriazis GA. 2016. Disruption of the sugar-sensing receptor T1R2 attenuates metabolic derangements associated with diet-induced obesity. Am J Physiol Endocrinol Metab. 310:E688-E698.
114. van Strien T, Donker MH, Ouwens MA. 2016. Is desire to eat in response to positive emotions an 'obese' eating style: is Kummerspeck for some people a misnomer? Appetite. 100:225-235.
115. Tam J, Cinar R, Liu J, Godlewski G, Wesley D, Jourdan T, Szanda G, Mukhopadhyay B, Chedester L, Liow JS, et al. 2012. Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab. 16:167-179.
116. Tang DW, Fellows LK, Small DM, Dagher A. 2012. Food and drug cues activate similar brain regions: a meta-analysis of functional MRI studies. Physiol Behav. 106:317-324.
117. Thomas G, Betters JL, Lord CC, Brown AL, Marshall S, Ferguson D, Sawyer J, Davis MA, Melchior JT, Blume LC, et al. 2013. The serine hydrolase ABHD6 is a critical regulator of the metabolic syndrome. Cell Rep. 5:508-520.
118. Umabiki M, Kotani K, Tsuzaki K, Higashi A, Sakane N. 2011. Sweet taste and (AAT)12 repeat in the cannabinoid receptor gene in obese females. Endocr J. 58:323-324.
119. Varga ZV, Giricz Z, Liaudet L, Haskó G, Ferdinandy P, Pacher P. 2015. Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta. 1852:232-242.
120. Vendrame S, Del Bo' C, Ciappellano S, Riso P, Klimis-Zacas D. 2016. Berry fruit consumption and metabolic syndrome. Antioxidants. 5:34.
121. Verty AN, Stefanidis A, McAinch AJ, Hryciw DH, Oldfield B. 2015. Antiobesity effect of the CB2 receptor agonist JWH-015 in diet-induced obese mice. PLoS One. 10:e0140592.
122. Viscomi MT, Oddi S, Latini L, Pasquariello N, Florenzano F, Bernardi G, Molinari M, Maccarrone M. 2009. Selective CB2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway. J Neurosci. 29:4564-4570.
123. Wang M, Abais JM, Meng N, Zhang Y, Ritter JK, Li PL, Tang WX. 2014. Upregulation of cannabinoid receptor-1 and fibrotic activation of mouse hepatic stellate cells during Schistosoma J. infection: role of NADPH oxidase. Free Radic Biol Med. 71:109-120.
124. Ward SJ, Dykstra LA. 2005. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940). Behav Pharmacol. 16:381-388.
125. Watanabe S, Doshi M, Hamazaki T. 2003. n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids. 69:51-59.
126. Wei D, Lee D, Li D, Daglian J, Jung KM, Piomelli D. 2016. A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice. Psychopharmacology (Berl). 233:1911-1919.
127. Wei Y, Wang X, Wang L. 2009. Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells. Mol Vis. 15:1243-1251. Available at http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 2697670&tool=pmcentrez&rendertype=abstract%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/19547718.
128. White MA, Grilo CM. 2005. Psychometric properties of the Food Craving Inventory among obese patients with binge eating disorder. Eat Behav. 6:239-245.
129. Wierucka-Rybak M, Wolak M, Bojanowska E. 2014. The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet. J Physiol Pharmacol 65: 487-96. Available at http://www.ncbi.nlm.nih.gov/pubmed/25179081.
130. Witkamp R. 2016. Fatty acids, endocannabinoids and inflammation. Eur J Pharmacol. 785:96-107.
131. Yoshida R, Niki M, Jyotaki M, Sanematsu K, Shigemura N, Ninomiya Y. 2013. Modulation of sweet responses of taste receptor cells. Semin Cell Dev Biol. 24:226-231.
132. Yoshida R, Ohkuri T, Jyotaki M, Yasuo T, Horio N, Yasumatsu K, Sanematsu K, Shigemura N, Yamamoto T, Margolskee RF, et al. 2010. Endocannabinoids selectively enhance sweet taste. Proc Natl Acad Sci U S A. 107:935-939.